ALEXANDRIA, Va., July 13, 2015 /PRNewswire/ -- EAS Consulting Group, LLC is very pleased to welcome Nancy Chew as the new Senior Advisor for New Product Development and Submissions. Ms. Chew has been an EAS Expert Consultant since 2009 and has been instrumental in helping EAS clients gain approvals for pharmaceutical and medical device applications. Her addition to the senior leadership team at EAS further solidifies EAS as the leading consulting company in regulatory matters pertaining to all FDA regulated areas including pharmaceuticals, OTCs and medical devices.
Ms. Chew consults with an international client base on matters pertaining to FDA regulation in the areas of toxicology, general management, strategic planning, licensing assessments, as well as regulatory research, analysis, and opinion. She has great expertise in assisting with every step of the study and development process, from the preparation of data in support of applications and protocol design for studies in further support to the technical preparation of NDAs, ANDAs, INDs as well as those submissions and background data required of medical devices. She has far reaching expertise in regulatory affairs and biomedical product development and was elected as a Fellow by the Regulatory Affairs Professional Society in 2009.
Nancy Chew joins a team of EAS Senior Advisors that are leaders in their fields in developing regulatory compliant strategies, serving as expert witnesses and providing expert regulatory advice:
- Jeffrey Springer, Senior Advisor for FDA Regulatory and Legal Matters,
- Anthony C. Celeste, Senior Advisor for Pharmaceutical Regulatory Affairs,
- Elizabeth Campbell, Senior Advisor for Labeling and Claims,
- Stephen Sundlof, D.V.M., Ph.D., Senior Advisor for Animal and Human Food Safety,
- Robert L. Martin, Senior Advisor for Food and Color Additive Safety,
- John Bailey, Senior Advisor for Colors and Cosmetics,
- William (Bill) Ment, Senior Advisor for Drug/Dietary Supplement Audit Services
We welcome Nancy Chew and are pleased that EAS continues to provide such a high level of technical consultation for our clients. She will be helping to expand our services to clients who wish to bring new drugs and medical devices to market.
About EAS Consulting Group, LLC
EAS Consulting Group specializes in FDA regulatory matters in the supplement, pharmaceutical, medical device, food, tobacco and cosmetics industries, including assistance in tailored compliance trainings, 483 responses, mock-FDA audits, labeling compliance and more. EAS is staffed with former industry experts and FDA officials who have expertise in both FDA policies and enforcement.
Contact: Cathryn Sacra 571-447-5505
SOURCE EAS Consulting Group, LLC